SCHEMBL5814889

SCHEMBL5814889

CCOC(=O)N1CCC(c2nc(-c3ccccc3F)c(-c3ccnc(N[C@@H](C)c4ccccc4)n3)s2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 5/20 0.45
RAF1 P04049 1/20 0.45
ERBB2 P04626 1/20 0.45
SRC P12931 1/20 0.45
KDR P35968 1/20 0.45
MAPK8 P45983 1/20 0.45
MAPK9 P45984 1/20 0.45
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 1/20 0.42
GAA P10253 1/20 0.42
MAPK1 P28482 1/20 0.42
KMT2A Q03164 1/20 0.42
HSD17B10 Q99714 1/20 0.42
NR1I2 O75469 1/20 0.42
MAPK14 Q16539 8/20 0.40
KCNH2 Q12809 1/20 0.39
TP53 P04637 2/20 0.39
MAPK13 O15264 3/20 0.38
MAPK12 P53778 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5818153 0.90 EGFR (0.57) EGFRRAF1ERBB2SRCKDR
SCHEMBL6220155 0.90 EGFR (0.57) EGFRRAF1ERBB2SRCKDR
SCHEMBL6220153 0.90 EGFR (0.57) EGFRRAF1ERBB2SRCKDR
SCHEMBL5819312 0.88 EGFR (0.50) EGFRRAF1ERBB2SRCKDR
SCHEMBL5817915 0.87 CDK2 (0.51) EGFRMAPK8MAPK9KDM4EMEN1
SCHEMBL5819401 0.86 MAPK9 (0.46) EGFRRAF1ERBB2SRCKDR
SCHEMBL5819343 0.86 EGFR (0.49) EGFRRAF1ERBB2SRCKDR
SCHEMBL5814019 0.86 EGFR (0.59) EGFRRAF1ERBB2SRCKDR
SCHEMBL5812677 0.86 CDK2 (0.48) EGFRMAPK8MAPK9KDM4EMEN1
SCHEMBL5817835 0.85 ALDH1A1 (0.43) EGFRKDM4EMEN1ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO claimed